Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer.

Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer. Clin Cancer Res. 2017 Aug 01; 23(15):4493-4500.

View in: PubMed

subject areas

Adult
Aged
Anthracyclines
Breast Neoplasms
DNA Breaks, Double-Stranded
DNA Damage
DNA Replication
Female
Gene Expression Regulation, Neoplastic
Genomic Instability
Homologous Recombination
Humans
Middle Aged
Neoplasm, Residual
Preoperative Period

authors with profiles

Philip P. Connell
Sean Pitroda
Ralph R. Weichselbaum